Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tcf4
|
ENSMUSG00000053477.9 | transcription factor 4 |
Mesp1
|
ENSMUSG00000030544.5 | mesoderm posterior 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_79801544_79801695 | Mesp1 | 7831 | 0.098237 | 0.65 | 7.6e-08 | Click! |
chr7_79792940_79793330 | Mesp1 | 653 | 0.515385 | 0.21 | 1.3e-01 | Click! |
chr7_79792729_79792903 | Mesp1 | 972 | 0.348094 | 0.14 | 3.2e-01 | Click! |
chr18_69415534_69415940 | Tcf4 | 160 | 0.973924 | 0.59 | 2.6e-06 | Click! |
chr18_69680737_69680888 | Tcf4 | 1113 | 0.652613 | 0.51 | 6.3e-05 | Click! |
chr18_69562561_69563011 | Tcf4 | 221 | 0.951711 | -0.51 | 7.2e-05 | Click! |
chr18_69428565_69428730 | Tcf4 | 12750 | 0.278102 | 0.46 | 4.2e-04 | Click! |
chr18_69501824_69501975 | Tcf4 | 941 | 0.681859 | -0.45 | 5.2e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_119006528_119007145 | 33.43 |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
119 |
0.97 |
chr4_107366540_107366691 | 23.77 |
Ndc1 |
NDC1 transmembrane nucleoporin |
1169 |
0.38 |
chr7_19800658_19801013 | 22.72 |
Cblc |
Casitas B-lineage lymphoma c |
4026 |
0.09 |
chr9_94659545_94660075 | 18.03 |
Gm29395 |
predicted gene 29395 |
9008 |
0.16 |
chr12_25092319_25093283 | 16.00 |
Id2 |
inhibitor of DNA binding 2 |
3286 |
0.21 |
chr1_12657409_12657900 | 14.50 |
Gm6216 |
predicted gene 6216 |
1787 |
0.32 |
chr2_68431348_68431518 | 12.15 |
Stk39 |
serine/threonine kinase 39 |
40507 |
0.15 |
chrX_123943434_123943951 | 10.99 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chrX_123721926_123722462 | 10.85 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123271195_123271712 | 10.72 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr11_69965261_69965757 | 10.68 |
Cldn7 |
claudin 7 |
113 |
0.88 |
chr11_96929113_96929565 | 10.64 |
Prr15l |
proline rich 15-like |
15 |
0.95 |
chrX_123500550_123501093 | 10.63 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr9_109094576_109096217 | 10.57 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr11_68556004_68556202 | 10.34 |
Mfsd6l |
major facilitator superfamily domain containing 6-like |
83 |
0.96 |
chr2_26139656_26141133 | 10.31 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr4_156059768_156060161 | 10.03 |
Gm13648 |
predicted gene 13648 |
162 |
0.77 |
chr14_62798727_62798915 | 9.96 |
Gm18146 |
predicted gene, 18146 |
19124 |
0.12 |
chr5_134946861_134947243 | 9.80 |
Cldn4 |
claudin 4 |
118 |
0.91 |
chr14_47346503_47346654 | 9.67 |
Lgals3 |
lectin, galactose binding, soluble 3 |
21173 |
0.09 |
chr11_8572842_8572993 | 9.64 |
Tns3 |
tensin 3 |
6204 |
0.33 |
chr2_153492229_153493481 | 9.58 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr5_64626415_64626798 | 9.10 |
Gm42565 |
predicted gene 42565 |
9234 |
0.12 |
chr11_109555645_109556032 | 9.03 |
Arsg |
arylsulfatase G |
12084 |
0.16 |
chr11_83078543_83078694 | 8.90 |
Gm20234 |
predicted gene, 20234 |
7372 |
0.08 |
chr14_48475621_48476075 | 8.11 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr6_124718799_124718986 | 8.07 |
Gm15884 |
predicted gene 15884 |
61 |
0.79 |
chr7_19800187_19800338 | 8.06 |
Cblc |
Casitas B-lineage lymphoma c |
3453 |
0.09 |
chr7_145205543_145206950 | 8.03 |
Smim38 |
small integral membrane protein 38 |
936 |
0.61 |
chr2_148018222_148018401 | 7.89 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
19959 |
0.17 |
chr4_156077703_156078324 | 7.85 |
Gm13648 |
predicted gene 13648 |
18211 |
0.07 |
chr7_29281838_29282175 | 7.66 |
Spint2 |
serine protease inhibitor, Kunitz type 2 |
94 |
0.94 |
chr12_73546456_73546654 | 7.60 |
Tmem30b |
transmembrane protein 30B |
163 |
0.93 |
chr12_25012100_25012275 | 7.48 |
Kidins220 |
kinase D-interacting substrate 220 |
4799 |
0.21 |
chr2_168023853_168024004 | 7.44 |
Ripor3 |
RIPOR family member 3 |
13310 |
0.14 |
chr7_79888694_79888887 | 7.29 |
Anpep |
alanyl (membrane) aminopeptidase |
27731 |
0.08 |
chr14_120371756_120371919 | 7.28 |
Mbnl2 |
muscleblind like splicing factor 2 |
7404 |
0.24 |
chr17_28769114_28769410 | 7.26 |
Mapk13 |
mitogen-activated protein kinase 13 |
35 |
0.96 |
chr4_11386541_11386917 | 7.23 |
Esrp1 |
epithelial splicing regulatory protein 1 |
50 |
0.97 |
chr10_39659287_39660442 | 7.22 |
2900078I11Rik |
RIKEN cDNA 2900078I11 gene |
1438 |
0.28 |
chr5_138846748_138847084 | 7.12 |
Gm5294 |
predicted gene 5294 |
26836 |
0.17 |
chr11_120744550_120744746 | 7.10 |
Cbr2 |
carbonyl reductase 2 |
12534 |
0.06 |
chr6_125321087_125321367 | 7.08 |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
22 |
0.95 |
chr16_4549405_4549570 | 7.05 |
Tfap4 |
transcription factor AP4 |
3475 |
0.17 |
chr7_44484045_44484471 | 6.99 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
259 |
0.76 |
chr4_148947936_148948318 | 6.96 |
Gm13205 |
predicted gene 13205 |
787 |
0.46 |
chr2_102066323_102066575 | 6.88 |
Gm13920 |
predicted gene 13920 |
8862 |
0.21 |
chr8_111393298_111394128 | 6.82 |
Fa2h |
fatty acid 2-hydroxylase |
105 |
0.96 |
chr12_79674954_79675872 | 6.79 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr2_103144443_103144797 | 6.74 |
Gm13874 |
predicted gene 13874 |
33167 |
0.13 |
chr11_100402751_100403046 | 6.73 |
Gm12348 |
predicted gene 12348 |
1390 |
0.2 |
chr11_24470582_24470747 | 6.69 |
4933430M04Rik |
RIKEN cDNA 4933430M04 gene |
11245 |
0.22 |
chr6_94203901_94204242 | 6.68 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
78954 |
0.1 |
chr18_74794167_74794382 | 6.65 |
Acaa2 |
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
891 |
0.54 |
chr8_122421630_122421919 | 6.65 |
Il17c |
interleukin 17C |
246 |
0.83 |
chr17_14244358_14244539 | 6.64 |
Gm34567 |
predicted gene, 34567 |
5403 |
0.19 |
chr14_101839764_101840716 | 6.60 |
Lmo7 |
LIM domain only 7 |
57 |
0.98 |
chr8_61390721_61391427 | 6.56 |
Gm7432 |
predicted gene 7432 |
9687 |
0.19 |
chr8_94362955_94363147 | 6.55 |
Slc12a3 |
solute carrier family 12, member 3 |
6740 |
0.11 |
chr7_29469550_29470116 | 6.50 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
35619 |
0.12 |
chr1_191802555_191802730 | 6.47 |
Gm20203 |
predicted gene, 20203 |
11328 |
0.13 |
chr7_127928682_127928988 | 6.47 |
Prss8 |
protease, serine 8 (prostasin) |
1260 |
0.21 |
chr15_101235342_101236406 | 6.45 |
A330009N23Rik |
RIKEN cDNA A330009N23 gene |
10688 |
0.09 |
chr18_74442215_74442630 | 6.45 |
Myo5b |
myosin VB |
115 |
0.97 |
chr9_45203971_45204289 | 6.44 |
Tmprss4 |
transmembrane protease, serine 4 |
38 |
0.95 |
chr17_14234882_14235311 | 6.44 |
Gm34567 |
predicted gene, 34567 |
14755 |
0.16 |
chr11_33952185_33952349 | 6.32 |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
10746 |
0.23 |
chr19_21628321_21628495 | 6.26 |
1110059E24Rik |
RIKEN cDNA 1110059E24 gene |
2360 |
0.32 |
chr3_60057433_60057585 | 6.25 |
Sucnr1 |
succinate receptor 1 |
24360 |
0.14 |
chr8_123708869_123709041 | 6.24 |
6030466F02Rik |
RIKEN cDNA 6030466F02 gene |
25003 |
0.06 |
chr18_22649541_22649716 | 6.21 |
Nol4 |
nucleolar protein 4 |
178734 |
0.03 |
chr16_97632907_97633099 | 6.20 |
Tmprss2 |
transmembrane protease, serine 2 |
21808 |
0.2 |
chr11_100088529_100088680 | 6.19 |
Krt32 |
keratin 32 |
378 |
0.67 |
chr7_44668477_44668662 | 6.19 |
2310016G11Rik |
RIKEN cDNA 2310016G11 gene |
336 |
0.66 |
chr6_90712861_90713488 | 6.18 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
3355 |
0.21 |
chr18_65025526_65026378 | 6.16 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
150 |
0.97 |
chr5_119070049_119070379 | 6.14 |
1700081H04Rik |
RIKEN cDNA 1700081H04 gene |
38020 |
0.17 |
chr9_121415591_121416113 | 6.04 |
Trak1 |
trafficking protein, kinesin binding 1 |
123 |
0.97 |
chr1_193152702_193153255 | 6.03 |
Irf6 |
interferon regulatory factor 6 |
133 |
0.93 |
chr14_27038788_27039646 | 6.00 |
Il17rd |
interleukin 17 receptor D |
39 |
0.98 |
chr19_58759014_58759207 | 6.00 |
Pnliprp2 |
pancreatic lipase-related protein 2 |
609 |
0.66 |
chr13_41423741_41424028 | 5.98 |
Gm48570 |
predicted gene, 48570 |
21593 |
0.14 |
chr16_57686135_57686316 | 5.92 |
Col8a1 |
collagen, type VIII, alpha 1 |
68490 |
0.09 |
chr1_107942038_107942203 | 5.89 |
D830032E09Rik |
RIKEN cDNA D830032E09 gene |
5411 |
0.2 |
chr13_98689980_98690224 | 5.89 |
Tmem171 |
transmembrane protein 171 |
4666 |
0.16 |
chr1_61639126_61639591 | 5.86 |
Pard3b |
par-3 family cell polarity regulator beta |
115 |
0.96 |
chr8_23934635_23934786 | 5.85 |
Zmat4 |
zinc finger, matrin type 4 |
5657 |
0.32 |
chrX_145497564_145497742 | 5.83 |
Amot |
angiomotin |
7491 |
0.28 |
chr18_74443566_74443891 | 5.82 |
Myo5b |
myosin VB |
1121 |
0.5 |
chr3_89280469_89281651 | 5.76 |
Efna1 |
ephrin A1 |
82 |
0.91 |
chr13_72419489_72419940 | 5.75 |
Rpl9-ps4 |
ribosomal protein L9, pseudogene 4 |
35626 |
0.14 |
chr19_24607991_24608142 | 5.73 |
Gm50341 |
predicted gene, 50341 |
51714 |
0.11 |
chr11_120744205_120744425 | 5.70 |
Cbr2 |
carbonyl reductase 2 |
12201 |
0.06 |
chr12_76547355_76548308 | 5.70 |
AI463170 |
expressed sequence AI463170 |
16 |
0.94 |
chr5_135001339_135001605 | 5.69 |
Wbscr25 |
Williams Beuren syndrome chromosome region 25 (human) |
122 |
0.9 |
chr3_145987459_145988897 | 5.66 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
41 |
0.98 |
chr8_122460615_122460837 | 5.65 |
Snai3 |
snail family zinc finger 3 |
7 |
0.94 |
chr19_7605885_7606822 | 5.62 |
Lgals12 |
lectin, galactose binding, soluble 12 |
750 |
0.59 |
chr10_79824446_79824758 | 5.61 |
Misp |
mitotic spindle positioning |
85 |
0.91 |
chr4_133518859_133519071 | 5.53 |
Kdf1 |
keratinocyte differentiation factor 1 |
2 |
0.96 |
chr9_21312247_21312534 | 5.51 |
Ap1m2 |
adaptor protein complex AP-1, mu 2 subunit |
53 |
0.94 |
chr16_4642870_4643151 | 5.50 |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
3021 |
0.14 |
chr19_53080891_53081464 | 5.47 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr17_66546834_66546985 | 5.45 |
Gm49938 |
predicted gene, 49938 |
14806 |
0.16 |
chr1_37666566_37667022 | 5.43 |
4930470B04Rik |
RIKEN cDNA 4930470B04 gene |
6072 |
0.19 |
chr15_76816855_76818442 | 5.43 |
Arhgap39 |
Rho GTPase activating protein 39 |
322 |
0.82 |
chr16_57398304_57398647 | 5.40 |
Filip1l |
filamin A interacting protein 1-like |
45198 |
0.13 |
chr4_156055284_156055465 | 5.31 |
Mir200b |
microRNA 200b |
376 |
0.4 |
chr4_142007432_142007583 | 5.30 |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
4130 |
0.15 |
chr15_79282501_79283041 | 5.28 |
Baiap2l2 |
BAI1-associated protein 2-like 2 |
2671 |
0.14 |
chr17_23660414_23660652 | 5.27 |
Bicdl2 |
BICD family like cargo adaptor 2 |
27 |
0.92 |
chr4_118543957_118544344 | 5.25 |
Tmem125 |
transmembrane protein 125 |
106 |
0.94 |
chr16_14936552_14936972 | 5.24 |
Efcab1 |
EF-hand calcium binding domain 1 |
30097 |
0.18 |
chr4_137480545_137480739 | 5.22 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
11839 |
0.13 |
chr2_172906015_172906191 | 5.22 |
Bmp7 |
bone morphogenetic protein 7 |
33989 |
0.15 |
chr3_101667532_101667878 | 5.17 |
Gm43135 |
predicted gene 43135 |
24084 |
0.18 |
chr14_31564746_31565181 | 5.15 |
Colq |
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
6823 |
0.16 |
chr11_98446586_98447075 | 5.15 |
Grb7 |
growth factor receptor bound protein 7 |
4 |
0.95 |
chr16_62814613_62814807 | 5.14 |
Stx19 |
syntaxin 19 |
34 |
0.97 |
chr19_5023458_5024512 | 5.14 |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
86 |
0.91 |
chr12_25209235_25209647 | 5.13 |
Gm47705 |
predicted gene, 47705 |
27673 |
0.16 |
chr17_8410480_8410631 | 5.10 |
T2 |
brachyury 2 |
13926 |
0.14 |
chr8_55358672_55359287 | 5.10 |
Gm20586 |
predicted gene, 20586 |
173312 |
0.03 |
chr1_92113452_92113892 | 5.10 |
Hdac4 |
histone deacetylase 4 |
341 |
0.92 |
chr5_35739652_35739964 | 5.08 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
179 |
0.94 |
chr4_118123073_118123998 | 5.07 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
11347 |
0.16 |
chr11_62643129_62643684 | 5.06 |
Lrrc75a |
leucine rich repeat containing 75A |
4634 |
0.1 |
chr2_30676522_30677628 | 5.03 |
Gm14486 |
predicted gene 14486 |
936 |
0.52 |
chr2_104378127_104378278 | 4.99 |
D430041D05Rik |
RIKEN cDNA D430041D05 gene |
32132 |
0.14 |
chr18_10946019_10946177 | 4.97 |
Gm7575 |
predicted gene 7575 |
17214 |
0.21 |
chr16_30055443_30055780 | 4.96 |
Hes1 |
hes family bHLH transcription factor 1 |
8773 |
0.15 |
chr15_100599610_100600576 | 4.95 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr7_112309752_112310043 | 4.94 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
6132 |
0.3 |
chr19_43890498_43890822 | 4.93 |
Dnmbp |
dynamin binding protein |
31 |
0.97 |
chr13_73713435_73713586 | 4.86 |
Slc6a19 |
solute carrier family 6 (neurotransmitter transporter), member 19 |
8645 |
0.14 |
chr15_82171117_82171277 | 4.84 |
Gm49502 |
predicted gene, 49502 |
14319 |
0.09 |
chr16_5131633_5131969 | 4.84 |
Ppl |
periplakin |
609 |
0.64 |
chr2_172862717_172863491 | 4.84 |
Gm22773 |
predicted gene, 22773 |
1237 |
0.55 |
chr6_4505141_4505904 | 4.83 |
Col1a2 |
collagen, type I, alpha 2 |
29 |
0.91 |
chr14_70174799_70175026 | 4.82 |
Pdlim2 |
PDZ and LIM domain 2 |
508 |
0.69 |
chr7_100492773_100493523 | 4.82 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
189 |
0.88 |
chr5_148361109_148361516 | 4.80 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
10234 |
0.23 |
chr1_157525893_157526398 | 4.75 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
2 |
0.97 |
chr15_84557260_84557932 | 4.74 |
Rtl6 |
retrotransposon Gag like 6 |
227 |
0.94 |
chr10_80398762_80400128 | 4.72 |
Mbd3 |
methyl-CpG binding domain protein 3 |
23 |
0.93 |
chr17_31834194_31834345 | 4.72 |
Sik1 |
salt inducible kinase 1 |
17306 |
0.15 |
chr16_55816273_55816463 | 4.70 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
2147 |
0.3 |
chr19_41013605_41013911 | 4.70 |
Dntt |
deoxynucleotidyltransferase, terminal |
15517 |
0.18 |
chr11_100286998_100287339 | 4.70 |
Gm14206 |
predicted gene 14206 |
4118 |
0.09 |
chr7_141042494_141042893 | 4.70 |
Gm45299 |
predicted gene 45299 |
8896 |
0.08 |
chr14_67877701_67877856 | 4.69 |
Mir6539 |
microRNA 6539 |
18033 |
0.22 |
chr6_125592165_125592329 | 4.68 |
Vwf |
Von Willebrand factor |
11303 |
0.21 |
chr7_141638576_141639348 | 4.67 |
Muc6 |
mucin 6, gastric |
16346 |
0.12 |
chr9_70229901_70230188 | 4.67 |
Myo1e |
myosin IE |
22676 |
0.2 |
chr6_119044221_119044382 | 4.67 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
35706 |
0.21 |
chr15_102016590_102017449 | 4.66 |
Krt18 |
keratin 18 |
11161 |
0.11 |
chr7_70606648_70606800 | 4.65 |
Gm44809 |
predicted gene 44809 |
13834 |
0.14 |
chr8_55355373_55355937 | 4.64 |
Gm20586 |
predicted gene, 20586 |
176636 |
0.03 |
chr13_44126293_44126452 | 4.63 |
Gm5083 |
predicted gene 5083 |
5078 |
0.19 |
chr2_167689966_167690179 | 4.58 |
Tmem189 |
transmembrane protein 189 |
250 |
0.78 |
chr4_129272138_129272635 | 4.58 |
Gm12976 |
predicted gene 12976 |
8656 |
0.11 |
chr18_36387226_36387479 | 4.58 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
21571 |
0.17 |
chr5_134985658_134985994 | 4.57 |
Cldn3 |
claudin 3 |
388 |
0.68 |
chr13_31547630_31548036 | 4.57 |
Foxq1 |
forkhead box Q1 |
8301 |
0.14 |
chr17_32577618_32577779 | 4.57 |
Gm50036 |
predicted gene, 50036 |
848 |
0.46 |
chr16_55523301_55523595 | 4.57 |
Mir5118 |
microRNA 5118 |
28717 |
0.22 |
chr5_64623783_64623974 | 4.56 |
Gm42565 |
predicted gene 42565 |
11962 |
0.12 |
chr13_109481377_109481735 | 4.54 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
39373 |
0.23 |
chr2_119236988_119237799 | 4.54 |
Spint1 |
serine protease inhibitor, Kunitz type 1 |
31 |
0.95 |
chr9_114886028_114886217 | 4.54 |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1-like |
22954 |
0.16 |
chr7_114203185_114203358 | 4.54 |
Gm45454 |
predicted gene 45454 |
5817 |
0.22 |
chr7_111174456_111174702 | 4.53 |
1700012D14Rik |
RIKEN cDNA 1700012D14 gene |
51895 |
0.11 |
chr11_95834197_95834457 | 4.52 |
Abi3 |
ABI gene family, member 3 |
1563 |
0.22 |
chr1_73914988_73915530 | 4.51 |
Tns1 |
tensin 1 |
12958 |
0.2 |
chr6_134111566_134111964 | 4.51 |
Gm43984 |
predicted gene, 43984 |
27164 |
0.16 |
chr7_44669263_44669476 | 4.49 |
Myh14 |
myosin, heavy polypeptide 14 |
21 |
0.94 |
chr17_31322449_31322631 | 4.47 |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
286 |
0.88 |
chr12_25108855_25109026 | 4.46 |
Id2 |
inhibitor of DNA binding 2 |
11800 |
0.15 |
chr2_154427863_154428053 | 4.44 |
Cbfa2t2 |
CBFA2/RUNX1 translocation partner 2 |
8523 |
0.17 |
chr2_32538528_32538837 | 4.44 |
Fam102a |
family with sequence similarity 102, member A |
1508 |
0.22 |
chr7_16815354_16816404 | 4.44 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr11_69816669_69816820 | 4.42 |
Gm39566 |
predicted gene, 39566 |
1446 |
0.14 |
chr1_72174262_72174463 | 4.42 |
Mreg |
melanoregulin |
37945 |
0.11 |
chr11_69858197_69858481 | 4.41 |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
369 |
0.62 |
chr3_94650538_94650690 | 4.40 |
Gm10972 |
predicted gene 10972 |
7516 |
0.1 |
chr2_25363323_25363493 | 4.40 |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
290 |
0.75 |
chr10_115561259_115561449 | 4.39 |
A930009A15Rik |
RIKEN cDNA A930009A15 gene |
8632 |
0.2 |
chr3_94693305_94693640 | 4.39 |
Selenbp2 |
selenium binding protein 2 |
84 |
0.95 |
chr15_77833162_77833493 | 4.36 |
Gm22107 |
predicted gene, 22107 |
7429 |
0.15 |
chr17_5896167_5896368 | 4.35 |
Gm8376 |
predicted gene 8376 |
42820 |
0.11 |
chr2_143852696_143852937 | 4.35 |
Rps13-ps6 |
ribosomal protein S13, pseudogene 6 |
2833 |
0.2 |
chr8_120877093_120877244 | 4.33 |
Gm26878 |
predicted gene, 26878 |
3038 |
0.3 |
chr13_38170932_38171166 | 4.33 |
Dsp |
desmoplakin |
7318 |
0.17 |
chr2_72752705_72752995 | 4.33 |
6430710C18Rik |
RIKEN cDNA 6430710C18 gene |
1997 |
0.38 |
chr14_64427986_64428137 | 4.32 |
Msra |
methionine sulfoxide reductase A |
10782 |
0.26 |
chr15_38567275_38567506 | 4.32 |
Gm29697 |
predicted gene, 29697 |
6606 |
0.13 |
chr13_72199092_72199243 | 4.31 |
Gm4052 |
predicted gene 4052 |
151054 |
0.04 |
chr13_24261385_24261728 | 4.30 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
18930 |
0.13 |
chr1_37616482_37616964 | 4.30 |
4930556I23Rik |
RIKEN cDNA 4930556I23 gene |
2464 |
0.25 |
chr10_41552817_41553202 | 4.30 |
Ccdc162 |
coiled-coil domain containing 162 |
160 |
0.86 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
4.0 | 12.1 | GO:0032439 | endosome localization(GO:0032439) |
3.8 | 15.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.2 | 16.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.1 | 9.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.6 | 7.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.5 | 7.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.5 | 7.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.5 | 7.5 | GO:0003166 | bundle of His development(GO:0003166) |
2.5 | 7.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.3 | 7.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.3 | 7.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.2 | 12.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.0 | 4.1 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.0 | 6.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.0 | 10.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.0 | 6.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.0 | 5.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.9 | 5.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.9 | 3.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.9 | 1.9 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.9 | 9.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.9 | 5.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.8 | 7.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.8 | 7.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.8 | 5.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.8 | 1.8 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.8 | 8.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.7 | 5.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.7 | 5.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.6 | 4.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.6 | 4.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.6 | 4.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.6 | 4.7 | GO:0008050 | female courtship behavior(GO:0008050) |
1.5 | 9.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.5 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.5 | 12.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 4.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.5 | 1.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.5 | 1.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.5 | 4.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.5 | 4.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 4.3 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.4 | 2.9 | GO:0035973 | aggrephagy(GO:0035973) |
1.4 | 7.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.4 | 4.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.4 | 4.2 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.4 | 5.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.4 | 5.6 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 6.9 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
1.4 | 6.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.4 | 2.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 4.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.3 | 2.7 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.3 | 3.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.3 | 6.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.3 | 3.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.3 | 5.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.2 | 3.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.2 | 3.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.2 | 3.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.2 | 7.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.2 | 6.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.2 | 9.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.2 | 8.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.2 | 4.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.2 | 10.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.2 | 3.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.2 | 4.7 | GO:0051639 | actin filament network formation(GO:0051639) |
1.2 | 3.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.2 | 3.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.1 | 1.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.1 | 1.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 2.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.1 | 6.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.1 | 1.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.1 | 2.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.1 | 4.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.1 | 2.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 6.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
1.1 | 3.3 | GO:0021564 | vagus nerve development(GO:0021564) |
1.1 | 1.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 1.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.1 | 8.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.1 | 3.2 | GO:0060157 | urinary bladder development(GO:0060157) |
1.1 | 3.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.0 | 3.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.0 | 3.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.0 | 3.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 4.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.0 | 5.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.0 | 6.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.0 | 3.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.0 | 7.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.0 | 31.9 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
1.0 | 3.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 2.9 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.0 | 2.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.0 | 1.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.0 | 2.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 6.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.0 | 5.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.0 | 2.9 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.0 | 8.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.9 | 1.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.9 | 4.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.9 | 2.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.9 | 1.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.9 | 2.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 3.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.9 | 1.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 4.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 2.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 9.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.9 | 2.7 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.9 | 4.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.9 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 7.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.9 | 1.8 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.9 | 6.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.9 | 7.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.9 | 4.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.9 | 3.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.9 | 0.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.9 | 17.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.9 | 8.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 2.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.9 | 3.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.9 | 3.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.8 | 3.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 7.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 0.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.8 | 2.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.8 | 1.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 1.6 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.8 | 1.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.8 | 4.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 2.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.8 | 3.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.8 | 3.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.8 | 2.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.8 | 7.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 3.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.8 | 3.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.8 | 6.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.8 | 3.0 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 2.3 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.8 | 2.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.8 | 4.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 3.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.7 | 3.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.7 | 1.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 2.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 8.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 4.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.7 | 2.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 0.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 2.1 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 1.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.7 | 0.7 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.7 | 2.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.7 | 0.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.7 | 0.7 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.7 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 4.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 0.7 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.7 | 4.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 1.4 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.7 | 1.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.7 | 4.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.7 | 2.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.7 | 3.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 2.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 0.7 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 1.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.7 | 4.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.7 | 4.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 5.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.7 | 5.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.7 | 2.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 5.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 1.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.6 | 3.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 1.9 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.6 | 3.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 3.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 1.9 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 17.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.6 | 3.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.6 | 1.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 1.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 0.6 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.6 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 3.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 2.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.6 | 1.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.6 | 9.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.6 | 1.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 1.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 1.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 0.6 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 1.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 3.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 3.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.6 | 2.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.6 | 1.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 0.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.6 | 1.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.9 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.6 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 1.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 3.4 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.6 | 2.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.6 | 2.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.6 | 1.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.6 | 2.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 5.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 1.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.6 | 0.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.6 | 9.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.6 | 3.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.6 | 2.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 1.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 2.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.6 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.6 | 1.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.5 | 1.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.5 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.5 | 1.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 0.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.5 | 2.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.5 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 2.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 0.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 4.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.5 | 1.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 1.6 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.0 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.5 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.5 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 2.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 2.1 | GO:0030578 | PML body organization(GO:0030578) |
0.5 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 5.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 2.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 1.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 1.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 4.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 1.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 1.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 2.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 5.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.5 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 2.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 2.5 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 12.8 | GO:0031424 | keratinization(GO:0031424) |
0.5 | 1.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.5 | 1.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 3.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 2.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.5 | 1.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.5 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 2.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.5 | 0.5 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 2.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.5 | 0.9 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 1.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.5 | 0.5 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.5 | 1.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 2.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.5 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 2.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 0.9 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.5 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 2.7 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.5 | 2.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 1.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 3.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.5 | 3.6 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.4 | 3.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 1.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 1.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 1.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 2.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.3 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 1.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.4 | 1.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.4 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.3 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.4 | 1.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.4 | 2.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 1.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 3.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 2.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 0.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 0.4 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.4 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 3.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 1.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 1.3 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 0.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 0.8 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.4 | 4.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 1.7 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 1.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 2.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 1.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.4 | 1.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 0.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 0.8 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 0.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 2.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 1.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 2.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.4 | 0.8 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 1.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 1.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 0.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 5.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.4 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.4 | 1.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.4 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.4 | 0.4 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.4 | 1.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.4 | 1.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.4 | 0.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 0.4 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.4 | 0.8 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.4 | 3.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 2.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 2.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 9.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.4 | 0.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.4 | 0.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 1.9 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.4 | 1.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 0.4 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 1.1 | GO:2000343 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 3.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 4.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 2.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 0.4 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.4 | 3.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 3.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 1.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 0.7 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 3.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.4 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 0.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 1.4 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.4 | 1.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 0.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 1.0 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.3 | 3.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 2.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 0.7 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.3 | 1.0 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 2.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.3 | 1.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 5.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 2.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 3.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.0 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.3 | 1.3 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.3 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 2.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.6 | GO:0030903 | notochord development(GO:0030903) |
0.3 | 1.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 1.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 3.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 1.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 4.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.3 | 4.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 0.3 | GO:0048382 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) mesendoderm development(GO:0048382) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.3 | 0.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.3 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 1.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 1.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 9.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 2.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 0.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 4.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.3 | 9.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 1.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 3.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 4.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.6 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.3 | 1.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.9 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 0.6 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 0.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 2.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.3 | GO:1903147 | maintenance of protein location in mitochondrion(GO:0072656) negative regulation of mitophagy(GO:1903147) |
0.3 | 0.3 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.3 | 1.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 1.1 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 1.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 1.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 2.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 1.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 1.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.3 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 0.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 1.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 6.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.3 | 0.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 0.3 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 0.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.3 | 1.1 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.3 | 0.5 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.3 | 0.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.8 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 3.9 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.8 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 0.3 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.5 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 1.3 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.3 | 1.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 1.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 2.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 1.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 1.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 1.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 0.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.2 | 1.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 3.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 1.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 0.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.2 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 4.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.7 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.9 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 0.7 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.2 | 3.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 2.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.8 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 1.9 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 1.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.6 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.6 | GO:0070293 | renal absorption(GO:0070293) |
0.2 | 2.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 2.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 2.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.8 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 2.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.4 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.2 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 2.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 18.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.2 | 1.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 2.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 2.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 1.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 1.7 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 0.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.2 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.9 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 2.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 2.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.2 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.6 | GO:0044851 | hair cycle phase(GO:0044851) |
0.2 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.6 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 1.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.4 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 0.5 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 1.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 1.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 1.8 | GO:0002385 | mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.2 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 1.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.2 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 2.5 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.2 | 1.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 1.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 1.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 1.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.7 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 1.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.5 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 1.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 3.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 3.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 1.0 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.7 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.2 | 3.8 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.2 | 0.7 | GO:0070254 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.2 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.8 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 2.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 4.0 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 5.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.3 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.2 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.4 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 1.1 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.2 | 0.6 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.2 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.5 | GO:0061217 | regulation of mesonephros development(GO:0061217) |
0.2 | 0.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 1.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.9 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.6 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 1.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 1.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.3 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 1.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.8 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.5 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.1 | GO:0060977 | coronary vasculature morphogenesis(GO:0060977) |
0.1 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.1 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 1.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 1.7 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 2.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 3.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 1.4 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 1.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 1.7 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 2.1 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 2.4 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.2 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 1.0 | GO:0044246 | regulation of multicellular organismal metabolic process(GO:0044246) |
0.1 | 1.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.6 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.6 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 2.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.5 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.7 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 3.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.5 | GO:0001885 | endothelial cell development(GO:0001885) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 1.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.6 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.8 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 2.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.3 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.4 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.4 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.7 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 1.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 4.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0002580 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.1 | 0.5 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.4 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 1.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.2 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.0 | 1.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.3 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.7 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.3 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0048631 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
0.0 | 0.4 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.0 | 0.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.4 | GO:0097513 | myosin II filament(GO:0097513) |
3.0 | 9.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.5 | 19.8 | GO:0045179 | apical cortex(GO:0045179) |
2.3 | 41.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.2 | 8.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.0 | 8.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.0 | 5.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.6 | 11.5 | GO:0030056 | hemidesmosome(GO:0030056) |
1.5 | 5.9 | GO:1990357 | terminal web(GO:1990357) |
1.4 | 8.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.4 | 2.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.3 | 6.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.3 | 2.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.3 | 10.4 | GO:0005861 | troponin complex(GO:0005861) |
1.2 | 3.7 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 5.9 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 5.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 4.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 3.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.0 | 3.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 3.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.9 | 13.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.9 | 5.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 3.7 | GO:0035363 | histone locus body(GO:0035363) |
0.9 | 2.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 6.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 45.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.8 | 3.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 7.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 4.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 10.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 4.9 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 6.2 | GO:0042641 | actomyosin(GO:0042641) |
0.7 | 1.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 2.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 2.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 1.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.6 | 28.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 2.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 5.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 3.2 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 1.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 4.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 4.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 4.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 4.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 2.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 6.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 1.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 3.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 1.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 41.5 | GO:0005903 | brush border(GO:0005903) |
0.4 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 6.3 | GO:0043034 | costamere(GO:0043034) |
0.4 | 35.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.4 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 4.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 5.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 3.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 4.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 1.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 3.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 13.9 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 1.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 1.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 3.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 4.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 24.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 2.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 2.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 0.7 | GO:0043292 | contractile fiber(GO:0043292) |
0.3 | 86.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 1.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 5.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 3.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 6.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 0.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 2.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 4.4 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 10.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 4.3 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.3 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 0.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 7.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 1.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 10.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 15.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 5.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 1.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 2.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 4.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 1.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 3.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 3.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 1.6 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 4.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 1.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 50.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 3.7 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 10.8 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 33.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 6.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 1.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 9.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 7.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.3 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 3.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 5.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 4.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 5.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 9.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 4.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 5.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.3 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.4 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.3 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 9.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 3.4 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.1 | 4.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 5.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 2.7 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 4.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 1.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 26.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.3 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.0 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.6 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 14.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0071797 | LUBAC complex(GO:0071797) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.5 | 7.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
2.0 | 5.9 | GO:0048030 | disaccharide binding(GO:0048030) |
1.8 | 14.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.8 | 5.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.8 | 8.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.5 | 4.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.5 | 10.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.5 | 4.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.4 | 4.3 | GO:0030172 | troponin C binding(GO:0030172) |
1.4 | 4.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.4 | 14.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.3 | 4.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.3 | 9.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.3 | 6.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.3 | 7.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.2 | 16.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 7.3 | GO:0038132 | neuregulin binding(GO:0038132) |
1.2 | 19.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 9.5 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 3.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.1 | 3.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.1 | 4.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.1 | 3.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.0 | 4.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.0 | 11.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.0 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.0 | 6.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.0 | 4.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 2.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.0 | 2.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 4.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.9 | 7.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 11.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.9 | 3.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 5.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 4.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 2.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.9 | 3.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.9 | 2.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 2.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 2.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.9 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 3.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 2.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 6.6 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 7.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 2.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 2.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.7 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 2.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 7.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 12.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 2.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 2.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 2.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 2.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.7 | 2.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 2.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 15.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 9.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 1.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 4.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 3.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 0.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.6 | 3.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 3.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 3.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 2.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 3.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 14.0 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 9.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 5.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 3.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 1.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 2.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 4.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 2.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 1.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.6 | 1.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 2.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 1.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 8.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 2.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 1.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 1.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 3.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 3.1 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.5 | 2.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 10.3 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 4.6 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 16.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.5 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 3.4 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.5 | 1.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 6.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 6.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 2.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 10.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 2.8 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 1.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 5.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 2.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 3.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 0.9 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.5 | 5.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 1.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 4.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 11.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 3.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 4.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.8 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 2.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 1.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 1.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 7.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 2.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.6 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 1.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 6.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 3.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 3.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 15.1 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 1.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 1.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 1.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 1.9 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 7.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 3.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 3.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 11.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 2.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 4.0 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 3.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 3.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 2.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 7.4 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 1.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 9.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 6.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 11.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 6.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 2.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 4.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 7.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 16.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 2.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 10.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 3.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 0.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 9.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 5.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 0.9 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 1.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 4.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 1.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 4.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 2.9 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 1.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 1.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 0.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 5.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 4.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 28.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 2.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 5.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.7 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 5.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 2.0 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 1.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 12.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 2.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 3.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 2.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 5.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 2.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 1.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 3.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 2.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 7.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 5.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 2.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.5 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 2.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 14.6 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 2.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 3.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 2.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 2.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 4.3 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 3.0 | GO:0032866 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 4.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 3.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 6.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 5.1 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 1.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 34.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 25.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.5 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 1.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 5.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 15.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.2 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.1 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.7 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 20.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 4.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.1 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 18.2 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.1 | 35.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.5 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 1.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 14.1 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 5.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 7.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 2.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 1.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 5.7 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 3.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.5 | 16.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 9.6 | ST STAT3 PATHWAY | STAT3 Pathway |
1.0 | 26.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 23.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 20.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 6.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 5.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 16.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 6.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 26.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 7.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 3.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 10.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 20.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 4.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 9.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 6.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 14.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 16.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 4.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 1.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 16.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 4.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 7.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 5.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 14.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 4.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 9.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 7.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 4.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 5.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 4.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 4.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 6.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 39.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 2.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 8.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 2.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 17.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 2.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 3.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 6.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 6.8 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 3.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 4.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 3.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 3.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 28.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 2.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 7.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 4.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 3.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 5.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 2.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 26.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 8.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 3.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 27.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.9 | 18.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.4 | 40.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.2 | 16.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.0 | 3.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.0 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 21.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 8.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 34.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.7 | 4.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 17.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 5.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 3.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 6.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 1.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 24.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 9.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.6 | 23.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 3.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 20.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 4.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 5.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 4.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 4.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 6.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 6.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 2.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 3.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 3.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 21.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 2.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 8.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 8.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 21.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 2.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 7.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 6.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 4.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 3.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 7.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 2.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 7.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 1.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 7.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 20.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 5.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 2.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 3.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 5.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 0.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 2.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 6.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.4 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.2 | 1.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.0 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 8.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 4.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 5.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 4.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 8.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 3.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |